Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Satyanarayana R. Vaidya"'
Autor:
Jeremy A. Rhodes, Sameer Arora, Satyanarayana R. Vaidya, John P. Vavalle, Cassandra J. Ramm, Thomas G. Caranasos, Paula D. Strassle
Publikováno v:
Heart, Lung and Circulation. 26:840-845
Background The results from the PARTNER 2 trial showed the feasibility of transcatheter aortic valve replacement (TAVR) in intermediate surgical risk patients. Although low risk clinical trials will take time to conclude, some data has emerged compar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::104407e277ca0778d42dd92ea1b02cce
https://doi.org/10.1016/j.hlc.2016.12.003
https://doi.org/10.1016/j.hlc.2016.12.003
Publikováno v:
Cardiovascular Diagnosis and Therapy. 7:16-26
Background: The 2015 American College of Cardiology Foundation/American Heart Association (ACCF/AHA) focused update on primary percutaneous coronary intervention (PCI) for patients with ST-segment elevation myocardial infarction (STEMI) only gives a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b4b6cf4c37ad11915159991d0577360
https://doi.org/10.21037/cdt.2016.08.06
https://doi.org/10.21037/cdt.2016.08.06
Publikováno v:
Journal of Medical Cases. 8:77-80
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb75b4f46ff0cbbf2adc672df7210f2a
https://doi.org/10.14740/jmc2750w
https://doi.org/10.14740/jmc2750w
Autor:
Satyanarayana R. Vaidya, Santhosh Reddy Devarapally, Varakantham Monica, Dushyant Singh Dahiya
Publikováno v:
Journal of the American College of Cardiology. 75:462
The American Heart Association (AHA) 2014 guidelines advocate the use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) for primary prevention of atrial fibrillation (AF) in cases of heart failure or hypertens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7921d93bd5ab9464fcca57b272e471e
https://doi.org/10.1016/s0735-1097(20)31089-5
https://doi.org/10.1016/s0735-1097(20)31089-5
Publikováno v:
Cardiovascular diagnosis and therapy. 7(4)
Background: Type 2 myocardial infarction (MI) is an imbalance between myocardial oxygen demand and supply, leading to myocardial ischemia. It is not due to plaque rupture, and is usually caused by a condition other than coronary artery disease (CAD).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27374a5ce5bcc15739482edba86a6dc3
https://pubmed.ncbi.nlm.nih.gov/28890871
https://pubmed.ncbi.nlm.nih.gov/28890871
Autor:
Sameer Arora, Paula D. Strassle, Matthew A. Cavender, Thomas G. Caranasos, John P. Vavalle, Satyanarayana R. Vaidya, Jacob A. Misenheimer, Evan N. Wheeler, Cassandra J. Ramm, Jeremy A. Rhodes
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions. 91(4)
Background In the recently concluded PARTNER 2 trial, TF-TAVR cohort was shown to have lower risks of death or disabling strokes as compared to SAVR, whereas the outcomes with transthoracic TAVR were comparable with SAVR. Methods We searched PubMed,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba3d966eca7a707687ba1e7cbef8a5f7
https://pubmed.ncbi.nlm.nih.gov/29068166
https://pubmed.ncbi.nlm.nih.gov/29068166
Autor:
Sameer Arora, Cassandra J. Ramm, John P. Vavalle, Satyanarayana R. Vaidya, Thomas G. Caranasos, Paula D. Strassle
Publikováno v:
The American journal of cardiology. 120(2)
The results of the Placement of AoRtic TraNscathetER Valves (PARTNER) 2 trial established the feasibility of transcatheter aortic valve replacement (TAVR) for intermediate surgical risk patients. The expansion of TAVR into the low-risk patient popula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::828179e19ce8f114fd1544b22dbdbdf0
https://pubmed.ncbi.nlm.nih.gov/28532778
https://pubmed.ncbi.nlm.nih.gov/28532778
Publikováno v:
Journal of Xiangya Medicine. 2:55-55
Background: The efficacy and safety of newer oral anticoagulants (NOAs) compared to vitamin K antagonist (VKA) in preventing the recurrence of venous thromboembolism (VTE) is well documented. However, it still needs to be determined whether this patt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a705ce7493d1b4e88bffb4fbe702805c
https://doi.org/10.21037/jxym.2017.07.04
https://doi.org/10.21037/jxym.2017.07.04
Publikováno v:
Case Reports in Internal Medicine. 4:25
Primary cardiac tumors are very rare. Atrial myxomas are the most common primary tumors and are commonly located in the left atrium. Myxomas can cause mitral valve inflow obstruction and can present with clinical signs and symptoms of mitral stenosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35d2224452be7a03c365fb6561fec2d6
https://doi.org/10.5430/crim.v4n1p25
https://doi.org/10.5430/crim.v4n1p25
Publikováno v:
Case Reports in Internal Medicine. 3:57
Dense deposit disease (DDD) is a prototypical form of C3 Glomerulopathy that affects both children and adults at a rate of 2 to 3 people per million. It often progresses to ESRD and recurs after Renal Transplantation. DDD presentation for 10 years or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd9ec3ed981a517710adbad95b6450e9
https://doi.org/10.5430/crim.v3n3p57
https://doi.org/10.5430/crim.v3n3p57